Powered Echelon Device in VATS Surgery

Inclusion Criteria:

Suspected or confirmed NSCLC (up to and including Stage II)
Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
Performance status 0-1 (Eastern Cooperative Oncology Group classification)
ASA score < 3
No prior history of VATS or open lung surgery
Willing to give consent and comply with study-related evaluation and treatment schedule

Exclusion Criteria:

Active bacterial infection or fungal infection;
Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed)
Pregnancy
Physical or psychological condition which would impair study participation;
The patient is judged unsuitable for study participation by the Investigator for any other reason; or
Unable or unwilling to attend follow-up visits and examinations